Keywords: schering, ag, sells, pfizer, its, adp, cv

Schering AG sells Pfizer its ADP CV program

Article | 07 February 2005

Print This

German drugmaker Schering AG says it has sold the exclusive worldwide marketing and development rights to a new thrombosis drug, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in